Crestor
Trovati 8 articoli
- Crestor can reduce plaques that cause myocardial infarction
- Findings from the ASTEROID trial showed that patients with heart disease who took the maximum dose of Rosuvastatin ( 40 mg per day; Crestor ) for 24 months and achieved on average LDL cholesterol levels below 70 mg/dL and significant increases in HDL cholesterol, had a mean reduction in the plaqu... (Leggi Articolo)
- Lymphoma: statins do not interfere with Rituximab treatment
- Statins, drugs widely prescribed to lower cholesterol, do not interfere with a commonly used medication to treat lymphomas, according to a study presented at the 50th Annual Meeting of the American Society of Hematology ( ASH ) in San Francisco. In fact, statins, also known as HMG-CoA reductase i... (Leggi Articolo)
- Crestor effective at halting early atherosclerosis
- A study using ultrasound technology has found that Rosuvastatin ( Crestor ), a cholesterol-lowering drug, is also effective at halting early changes in the blood vessels that can lead to atherosclerosis. " Rosuvastatin arrested the progression of thickened carotid arteries compared to a placeb... (Leggi Articolo)
- Crestor to slow the progression of atherosclerosis in patients with elevated cholesterol, FDA approved
- The FDA ( Food and Drug Administration ) has approved Crestor ( Rosuvastatin ) as an adjunct to diet to slow the progression of atherosclerosis in patients with elevated cholesterol. The submission package to the FDA was based largely on the results of a pivotal study called METEOR ( Measurin... (Leggi Articolo)
- Crestor may reverse atherosclerosis in patients with coronary artery disease
- A two-year study demonstrated that Rosuvastatin ( Crestor ) reversed plaque build-up in the arteries of patients with evidence of coronary artery disease. This is the first time a statin has demonstrated regression of atherosclerosis in a major clinical study. Data showed that plaque build-... (Leggi Articolo)
- FDA: Crestor has a favorable risk/benefit ratio
- The Food and Drug Administration ( FDA ) issued a public health advisory, a patient information sheet and a corresponding healthcare professional information sheet further explaining the identified risks and benefits of Crestor ( Rosuvastatin ), a cholesterol-lowering drug. Extensive review o... (Leggi Articolo)
- Advanced prostate carcinoma: statins may reduce the risk
- Use of statins may reduce the risk of advanced prostate cancer, according to research that followed 34,428 U.S. men for more than a decade. The study found that men who used these medications had half the risk of advanced prostate cancer and a third of the risk of metastatic or fatal prostate ... (Leggi Articolo)
- Metabolic syndrome: treatment
- A study presented at the 40th Annual Meeting of the European Association for the Study of Diabetes ( EASD ), Munich, Germany, has showed that Rosuvastatin ( Crestor ) lowers LDL-cholesterol and raises HDL-cholesterol significantly more than Atorvastatin ( Lipitor ) in patients with the metaboli... (Leggi Articolo)
